| 1 | Choriocarcinoma | 34.5% |
| 2 | Neuroectodermal Tumors | 20.1% |
| 3 | Chordoma | 16.5% |
| 4 | Teratoma | 16.5% |
| 5 | Germinoma | 16.5% |
| 6 | Teratocarcinoma | 16.5% |
| 7 | Neoplasms, Neuroepithelial | 15.9% |
| 8 | Gliomatosis cerebri | 15.9% |
| 9 | leukemia | 15.2% |
| 10 | Neoplasms, Glandular and Epithelial | 15.2% |
| 11 | Hamartoma | 14.8% |
| 12 | Neoplasms, Hormone-Dependent | 14.8% |
| 13 | Neoplasms, Multiple Primary | 14.8% |
| 14 | Paraneoplastic Syndromes | 14.8% |
| 15 | Precancerous Conditions | 14.8% |
| 16 | Neoplasms, Second Primary | 14.8% |
| 17 | Dermoid Cyst | 14.4% |
| 18 | melanoma | 12.6% |
| 19 | Craniopharyngioma | 12.2% |
| 20 | Neuroectodermal Tumor, Melanotic | 12.2% |
| 21 | Neuroendocrine Tumors | 12.2% |
| 22 | Histiocytic Disorders, Malignant | 12.2% |
| 23 | Cyst | 12% |
| 24 | Neoplastic Processes | 12% |
| 25 | Neoplastic Syndromes, Hereditary | 12% |
| 26 | Neoplasms, Experimental | 11.8% |
| 27 | Carcinoma 256, Walker | 11.1% |
| 28 | Polyhydramnios | 11.1% |
| 29 | Obstetric Labor Complications | 11.1% |
| 30 | Ectopic Pregnancy | 11.1% |
| 31 | Pregnancy, Prolonged | 11.1% |
| 32 | Puerperal Disorders | 11.1% |
| 33 | Oligohydramnios | 11.1% |
| 34 | Prenatal Injuries | 11.1% |
| 35 | Carcinosarcoma | 11% |
| 36 | Hemangiosarcoma | 11% |
| 37 | lymphangiosarcoma | 11% |
| 38 | Leukemia, Experimental | 10.9% |
| 39 | Meningioma | 10.9% |
| 40 | Melanoma, Experimental | 10.5% |
| 41 | Carcinoma, Ehrlich Tumor | 10.5% |
| 42 | Carcinoma, Lewis Lung | 10.5% |
| 43 | Adenoma, Acidophil | 10.4% |
| 44 | Ganglioneuroma | 10.4% |
| 45 | Glioma | 10.4% |
| 46 | Malignant Glioma | 10.4% |
| 47 | Multiple Endocrine Neoplasia | 10.3% |
| 48 | Medulloblastoma | 10.2% |
| 49 | Lymphoma | 10.2% |
| 50 | Dysgerminoma | 10% |
| 51 | Seminoma | 10% |
| 52 | Neoplasms, Radiation-Induced | 9.9% |
| 53 | Abruptio Placentae | 9.7% |
| 54 | Placenta Accreta | 9.7% |
| 55 | Composite Lymphoma | 9.7% |
| 56 | Leukemia, Radiation-Induced | 9.5% |
| 57 | Carcinoid Tumor | 9.3% |
| 58 | Neurilemmoma | 9.3% |
| 59 | Fetal Diseases | 9.2% |
| 60 | Pregnancy Complications, Cardiovascular | 9.2% |
| 61 | Chorioamnionitis | 9.2% |
| 62 | Leukemia, Plasma Cell | 9.1% |
| 63 | Pregnancy Complications, Hematologic | 9% |
| 64 | Pregnancy Complications, Infectious | 9% |
| 65 | Fetal Death | 8.9% |
| 66 | Perinatal death | 8.9% |
| 67 | Morning Sickness | 8.8% |
| 68 | Hutchinson's Melanotic Freckle | 8.8% |
| 69 | Melanoma, Amelanotic | 8.8% |
| 70 | Sarcoma, Experimental | 8.7% |
| 71 | Adenoma | 8.5% |
| 72 | Ameloblastoma | 8.5% |
| 73 | Angiokeratoma | 8.5% |
| 74 | Carcinoma | 8.5% |
| 75 | Hemangioma | 8.5% |
| 76 | hemangiopericytoma | 8.5% |
| 77 | Lymphangioma | 8.5% |
| 78 | Mesenchymoma | 8.5% |
| 79 | Nevus | 8.5% |
| 80 | Hepatoblastoma | 8.5% |
| 81 | Mixed Tumor, Mullerian | 8.5% |
| 82 | Angiofibroma | 8.5% |
| 83 | Sarcoma | 8.5% |
| 84 | Epithelioma | 8.5% |
| 85 | Basal cell carcinoma | 8.3% |
| 86 | Carcinoma, Papillary | 8.3% |
| 87 | Squamous cell carcinoma | 8.3% |
| 88 | Chondrosarcoma | 8.3% |
| 89 | Cystadenoma | 8.3% |
| 90 | leiomyosarcoma | 8.3% |
| 91 | liposarcoma | 8.3% |
| 92 | Mesothelioma | 8.3% |
| 93 | synovial sarcoma | 8.3% |
| 94 | Angiomyolipoma | 8.3% |
| 95 | Clear Cell Sarcoma of Soft Tissue | 8.3% |
| 96 | Alveolar Soft Part Sarcoma | 8.3% |
| 97 | Paraneoplastic Encephalomyelitis | 8.3% |
| 98 | Sarcoma, Myeloid | 8.3% |
| 99 | Carcinoma, Basal Cell | 8.3% |
| 100 | Paraganglioma | 8.3% |
| 101 | Mammary Neoplasms, Experimental | 8.2% |
| 102 | Puerperal Infection | 8.2% |
| 103 | Postpartum Hemorrhage | 8.1% |
| 104 | Tuberous Sclerosis | 7.9% |
| 105 | Abdominal Neoplasms | 7.8% |
| 106 | Erythroplasia | 7.8% |
| 107 | Follicular cyst | 7.8% |
| 108 | Head and Neck Neoplasms | 7.8% |
| 109 | Mucocele | 7.8% |
| 110 | Pilonidal Cyst | 7.8% |
| 111 | Soft Tissue Neoplasms | 7.8% |
| 112 | Thoracic Neoplasms | 7.8% |
| 113 | Thyroglossal Cyst | 7.8% |
| 114 | Synovial Cyst | 7.8% |
| 115 | Aberrant Crypt Foci | 7.8% |
| 116 | Leukemia L1210 | 7.7% |
| 117 | Leukemia P388 | 7.7% |
| 118 | Acanthoma | 7.7% |
| 119 | Astrocytoma | 7.7% |
| 120 | Ependymoma | 7.7% |
| 121 | oligodendroglioma | 7.7% |
| 122 | Ganglioglioma | 7.7% |
| 123 | gliosarcoma | 7.7% |
| 124 | Anaplastic astrocytoma | 7.7% |
| 125 | Anaplastic Oligodendroglioma | 7.7% |
| 126 | Carcinoma, Lobular | 7.6% |
| 127 | Thymoma | 7.6% |
| 128 | Retinoblastoma | 7.5% |
| 129 | Gestational Diabetes | 7.5% |
| 130 | Endometrial Stromal Sarcoma | 7.4% |
| 131 | Nephroblastoma | 7.2% |
| 132 | Female Urogenital Diseases | 7.2% |
| 133 | Malignant Carcinoid Syndrome | 7.1% |
| 134 | Cystadenocarcinoma | 7% |
| 135 | Fibrosarcoma | 7% |
| 136 | Osteosarcoma | 7% |
| 137 | Mucoepidermoid Carcinoma | 7% |
| 138 | Plasmacytoma | 6.8% |
| 139 | Malignant histiocytosis | 6.8% |
| 140 | Histiocytic sarcoma | 6.8% |
| 141 | Digestive System Neoplasms | 6.5% |
| 142 | Endocrine Gland Neoplasms | 6.5% |
| 143 | Eye Neoplasms | 6.5% |
| 144 | Nervous System Neoplasms | 6.5% |
| 145 | Lymphomatoid Granulomatosis | 6.5% |
| 146 | Sarcoma 180 | 6.4% |
| 147 | Adenofibroma | 6.4% |
| 148 | Fibroadenoma | 6.4% |
| 149 | Malignant Fibrous Histiocytoma | 6.4% |
| 150 | Pheochromocytoma | 6.3% |
| 151 | Bone neoplasms | 6.3% |
| 152 | Leukoplakia | 6.3% |
| 153 | Lymphocele | 6.3% |
| 154 | Pancreatic Cyst | 6.3% |
| 155 | Skin Neoplasms | 6.3% |
| 156 | Hematologic Neoplasms | 6.3% |
| 157 | Glioblastoma | 6.3% |
| 158 | Neuroblastoma | 6.3% |
| 159 | Glioblastoma Multiforme | 6.3% |
| 160 | Barrett Esophagus | 6.2% |
| 161 | Breast Cyst | 6.2% |
| 162 | Actinic keratosis | 6.2% |
| 163 | Mediastinal Cyst | 6.2% |
| 164 | Neoplasm Invasiveness | 6.2% |
| 165 | Neoplasm Metastasis | 6.2% |
| 166 | Neoplasm Recurrence, Local | 6.2% |
| 167 | Parovarian Cyst | 6.2% |
| 168 | Pericardial Cyst | 6.2% |
| 169 | Splenic Neoplasms | 6.2% |
| 170 | Thymic Cyst | 6.2% |
| 171 | Carcinogenesis | 6.2% |
| 172 | Myxoid cyst | 6.2% |
| 173 | Metastasis | 6.2% |
| 174 | Abortion, Habitual | 6% |
| 175 | Dystocia | 6% |
| 176 | Eclampsia | 6% |
| 177 | Fetal Membranes, Premature Rupture | 6% |
| 178 | Placental Insufficiency | 6% |
| 179 | Pre-Eclampsia | 6% |
| 180 | Prenatal Exposure Delayed Effects | 6% |
| 181 | HELLP Syndrome | 6% |
| 182 | Placenta, Retained | 6% |
| 183 | Lymphangioleiomyomatosis | 6% |
| 184 | Multiple Endocrine Neoplasia Type 1 | 5.9% |
| 185 | Pregnancy Complications, Neoplastic | 5.8% |
| 186 | Uterine Inversion | 5.8% |
| 187 | Bowen's Disease | 5.7% |
| 188 | Rhabdomyosarcoma | 5.7% |
| 189 | Giant Cell Tumor of Bone | 5.7% |
| 190 | Corpus Luteum Cyst | 5.7% |
| 191 | Ovarian Cysts | 5.7% |
| 192 | Basal Cell Nevus Syndrome | 5.7% |
| 193 | Ganglioneuroblastoma | 5.7% |
| 194 | Hodgkin Disease | 5.6% |
| 195 | Lymphoma, Non-Hodgkin | 5.6% |
| 196 | Mesoblastic Nephroma | 5.3% |
| 197 | Liver Neoplasms, Experimental | 5.3% |
| 198 | Carcinoid Heart Disease | 5.3% |
| 199 | Acoustic Neuroma | 5.3% |
| 200 | Parathyroid Neoplasms | 5.2% |
| 201 | Peritoneal Neoplasms | 5.2% |
| 202 | Thyroid Neoplasm | 5.2% |
| 203 | Thyroid carcinoma | 5.2% |
| 204 | Adenocarcinoma | 5.2% |
| 205 | Carcinoma in Situ | 5.2% |
| 206 | Carcinoma, Transitional Cell | 5.2% |
| 207 | Phyllodes Tumor | 5.2% |
| 208 | Hemangioendothelioma | 5.2% |
| 209 | Lipoma | 5.2% |
| 210 | Myoma | 5.2% |
| 211 | Myxoma | 5.2% |
| 212 | Neuroma | 5.2% |
| 213 | Papilloma | 5.2% |
| 214 | Pseudomyxoma Peritonei | 5.2% |
| 215 | Papillomatosis | 5.2% |
| 216 | Angiolipoma | 5.2% |
| 217 | Myelolipoma | 5.2% |
| 218 | Neoplasms, Bone Tissue | 5.2% |
| 219 | Neoplasms, Fibrous Tissue | 5.2% |
| 220 | Smooth Muscle Tumor | 5.2% |
| 221 | Adenomatosis, Pulmonary | 5.2% |
| 222 | Adenomatous Polyps | 5.2% |
| 223 | Carcinoma, Large Cell | 5.2% |
| 224 | Carcinoma, Small Cell | 5.2% |
| 225 | Desmoplastic Small Round Cell Tumor | 5.2% |
| 226 | Chondroma | 5.2% |
| 227 | Enchondroma | 5.2% |
| 228 | Genital Neoplasms, Female | 5.2% |
| 229 | Dermatofibrosarcoma | 5.1% |
| 230 | Dermatofibrosarcoma Protuberans | 5.1% |
| 231 | Abortion, Veterinary | 5.1% |
| 232 | Pregnancy Complications, Parasitic | 5.1% |
| 233 | Neurofibrosarcoma | 5% |
| 234 | Uterine Rupture | 4.9% |
| 235 | Primary amyloidosis | 4.9% |
| 236 | Lactation Disorder | 4.9% |
| 237 | Mastitis | 4.9% |
| 238 | Depression, Postpartum | 4.9% |
| 239 | Embryo Loss | 4.9% |
| 240 | Carcinoma, Pancreatic Ductal | 4.9% |
| 241 | Fetal Resorption | 4.8% |
| 242 | Hyperemesis Gravidarum | 4.8% |
| 243 | Vipoma | 4.8% |
| 244 | Optic Nerve Glioma | 4.7% |
| 245 | Hepatocellular Adenoma | 4.6% |
| 246 | Pancreatic Neoplasm | 4.6% |
| 247 | Choledochal Cyst | 4.5% |
| 248 | Alveolar rhabdomyosarcoma | 4.4% |
| 249 | Retroperitoneal Neoplasms | 4.4% |
| 250 | Peutz-Jeghers Syndrome | 4.4% |
| 251 | Urologic Neoplasms | 4.4% |
| 252 | Adenomatous Polyposis Coli | 4.3% |
| 253 | Tracheal Neoplasms | 4.3% |
| 254 | granulosa cell tumor | 4.2% |
| 255 | Carcinoma, Ovarian Epithelial | 4.2% |
| 256 | Leukoplakia, Oral | 4.2% |
| 257 | Leukemia, Myelomonocytic, Chronic | 4.2% |
| 258 | Paraneoplastic Cerebellar Degeneration | 4.2% |
| 259 | Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative | 4.2% |
| 260 | Fetal Growth Retardation | 4.1% |
| 261 | Trophoblastic Neoplasms | 4.1% |
| 262 | Embolism, Amniotic Fluid | 4.1% |
| 263 | Neoplasms, Germ Cell and Embryonal | 4.1% |
| 264 | Fetal Hypoxia | 4.1% |
| 265 | Germ Cell Cancer | 4.1% |
| 266 | Fetal Alcohol Spectrum Disorders | 4.1% |
| 267 | Breech Presentation | 4% |
| 268 | Prolactinoma | 4% |
| 269 | Growth Hormone-Secreting Pituitary Adenoma | 4% |
| 270 | Stillbirth | 4% |
| 271 | Waldenstrom Macroglobulinemia | 3.8% |
| 272 | Multiple Myeloma | 3.8% |
| 273 | Esophageal Neoplasms | 3.7% |
| 274 | Limbic Encephalitis | 3.6% |
| 275 | Mouth Neoplasms | 3.6% |
| 276 | Central Nervous System Neoplasms | 3.6% |
| 277 | Vascular Neoplasms | 3.6% |
| 278 | Thymus Neoplasms | 3.6% |
| 279 | Premature Birth | 3.6% |
| 280 | Adenoid Cystic Carcinoma | 3.6% |
| 281 | fibroma | 3.6% |
| 282 | Fibromatosis | 3.6% |
| 283 | Osteoblastoma | 3.6% |
| 284 | Osteoma | 3.6% |
| 285 | Rhabdomyoma | 3.6% |
| 286 | Chondromatosis | 3.6% |
| 287 | Adenocarcinoma, Clear Cell | 3.6% |
| 288 | Cholangiocarcinoma | 3.6% |
| 289 | Cervical Intraepithelial Neoplasia | 3.6% |
| 290 | Hemangioblastoma | 3.6% |
| 291 | Lymphoma, Extranodal NK-T-Cell | 3.6% |
| 292 | Pancreatic Pseudocyst | 3.6% |
| 293 | Mastocytosis | 3.6% |
| 294 | Sturge-Weber Syndrome | 3.6% |
| 295 | Lymphatic Metastasis | 3.5% |
| 296 | Neoplasms, Unknown Primary | 3.5% |
| 297 | Leukemic Infiltration | 3.5% |
| 298 | Breast Neoplasms, Male | 3.5% |
| 299 | Neoplasm Micrometastasis | 3.5% |
| 300 | Triple Negative Breast Neoplasms | 3.5% |
| 301 | Denys-Drash Syndrome | 3.5% |
| 302 | Uterine Cervical Incompetence | 3.5% |
| 303 | Gastrointestinal Stromal Tumors | 3.5% |
| 304 | Hemangioma, Cavernous | 3.5% |
| 305 | Leukemia, T-Cell | 3.5% |
| 306 | Uterine Neoplasms | 3.5% |
| 307 | Vaginal Neoplasms | 3.5% |
| 308 | Vulvar Neoplasms | 3.5% |
| 309 | Uterine Cancer | 3.5% |
| 310 | Leukemia, B-Cell | 3.5% |
| 311 | neurofibroma | 3.5% |
| 312 | Lymphoma, Follicular | 3.5% |
| 313 | T-Cell Lymphoma | 3.5% |
| 314 | Mantle cell lymphoma | 3.5% |
| 315 | insulinoma | 3.4% |
| 316 | Polycystic Ovary Syndrome | 3.3% |
| 317 | Lambert-Eaton Myasthenic Syndrome | 3.3% |
| 318 | Testicular Neoplasms | 3.3% |
| 319 | ovarian neoplasm | 3.3% |
| 320 | Thyroid Nodule | 3.2% |
| 321 | Fallopian Tube Neoplasms | 3.2% |
| 322 | Renal Cell Carcinoma | 3.2% |
| 323 | Papillary Renal Cell Carcinoma | 3.2% |
| 324 | Carcinoma, Endometrioid | 3.2% |
| 325 | Meconium Aspiration Syndrome | 3.2% |
| 326 | Urologic Diseases | 3.1% |
| 327 | Adrenal Gland Neoplasms | 3.1% |
| 328 | Gastrointestinal Neoplasms | 3.1% |
| 329 | Genital Neoplasms, Male | 3.1% |
| 330 | Liver neoplasms | 3.1% |
| 331 | Uveal Neoplasms | 3.1% |
| 332 | Gastrinoma | 3% |
| 333 | Glucagonoma | 3% |
| 334 | Sebaceous Gland Neoplasms | 3% |
| 335 | Spinal Neoplasms | 3% |
| 336 | Bone Marrow Neoplasms | 3% |
| 337 | Opsoclonus-Myoclonus Syndrome | 3% |
| 338 | Mastocytoma | 2.9% |
| 339 | Galactorrhea | 2.9% |
| 340 | Mastocytosis, Systemic | 2.9% |
| 341 | Leukemia, Myeloid, Chronic-Phase | 2.9% |
| 342 | Leydig Cell Tumor | 2.9% |
| 343 | Xeroderma Pigmentosum | 2.9% |
| 344 | Adrenocortical carcinoma | 2.8% |
| 345 | Fibromatosis, Aggressive | 2.8% |
| 346 | Fibromatosis, Abdominal | 2.8% |
| 347 | Klatskin Tumor | 2.8% |
| 348 | Nasopharyngeal carcinoma | 2.7% |
| 349 | Myelitis, Transverse | 2.7% |
| 350 | Bladder Neoplasm | 2.6% |
| 351 | Kidney Neoplasm | 2.6% |
| 352 | Ureteral Neoplasms | 2.6% |
| 353 | Urethral Neoplasms | 2.6% |
| 354 | Urogenital Abnormalities | 2.6% |
| 355 | Endometrial Neoplasms | 2.4% |
| 356 | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 2.4% |
| 357 | Leukemia, Large Granular Lymphocytic | 2.4% |
| 358 | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 2.4% |
| 359 | Lymphoma, T-Cell, Cutaneous | 2.4% |
| 360 | Lymphoma, AIDS-Related | 2.4% |
| 361 | Enteropathy-Associated T-Cell Lymphoma | 2.4% |
| 362 | Primary Effusion Lymphoma | 2.4% |
| 363 | Nose Neoplasms | 2.3% |
| 364 | Meningeal Neoplasms | 2.3% |
| 365 | Palatal Neoplasms | 2.2% |
| 366 | Pituitary Adenoma | 2.1% |
| 367 | Pituitary Neoplasms | 2.1% |
| 368 | Endometriosis | 2% |
| 369 | Uterine Diseases | 2% |
| 370 | Vaginal Diseases | 2% |
| 371 | Vulvar Diseases | 2% |
| 372 | Endometrioma | 2% |
| 373 | Ear Neoplasms | 1.9% |
| 374 | Eyelid Neoplasms | 1.9% |
| 375 | Lung Neoplasms | 1.9% |
| 376 | Pleural Neoplasms | 1.9% |
| 377 | Dupuytren Contracture | 1.9% |
| 378 | Cell Transformation, Viral | 1.9% |
| 379 | Brain Neoplasms | 1.9% |
| 380 | Salivary Gland Neoplasms | 1.9% |
| 381 | Spinal Cord Neoplasms | 1.9% |
| 382 | Tongue Neoplasms | 1.9% |
| 383 | Urticaria Pigmentosa | 1.9% |
| 384 | Mycosis Fungoides | 1.8% |
| 385 | Lymphomatoid Papulosis | 1.8% |
| 386 | Plasmablastic lymphoma | 1.8% |
| 387 | Burkitt Lymphoma | 1.8% |
| 388 | Zollinger-Ellison syndrome | 1.8% |
| 389 | Pharyngeal Neoplasms | 1.7% |
| 390 | Bladder Exstrophy | 1.6% |
| 391 | Epispadias | 1.6% |
| 392 | Urinary Bladder Diseases | 1.6% |
| 393 | Infertility | 1.6% |
| 394 | Kidney Diseases | 1.6% |
| 395 | Ureteral Diseases | 1.6% |
| 396 | Urethral Diseases | 1.6% |
| 397 | Urination Disorders | 1.6% |
| 398 | Urolithiasis | 1.6% |
| 399 | Central Nervous System Cysts | 1.6% |
| 400 | Tuberculosis, Renal | 1.6% |
| 401 | Bile Duct Neoplasms | 1.6% |
| 402 | gallbladder neoplasm | 1.6% |
| 403 | Intestinal Neoplasms | 1.6% |
| 404 | Penile Neoplasms | 1.6% |
| 405 | Prostatic Neoplasms | 1.6% |
| 406 | Stomach Neoplasms | 1.6% |
| 407 | Polycythemia Vera | 1.6% |
| 408 | Endometritis | 1.6% |
| 409 | Meningeal Carcinomatosis | 1.6% |
| 410 | Hydatidiform Mole | 1.6% |
| 411 | Laryngeal neoplasm | 1.5% |
| 412 | Hydrops Fetalis | 1.5% |
| 413 | Multicystic Dysplastic Kidney | 1.4% |
| 414 | Sezary Syndrome | 1.4% |
| 415 | Anuria | 1.4% |
| 416 | Ureterolithiasis | 1.4% |
| 417 | Urinary tract infection | 1.4% |
| 418 | Nephrolithiasis | 1.4% |
| 419 | Horseshoe Kidney | 1.4% |
| 420 | Bronchial Neoplasms | 1.4% |
| 421 | Multiple Pulmonary Nodules | 1.3% |
| 422 | Supratentorial Neoplasms | 1.3% |
| 423 | Salpingitis | 1.3% |
| 424 | Vulvovaginitis | 1.3% |
| 425 | Sexually Transmitted Diseases | 1.2% |
| 426 | Urinary Bladder Fistula | 1.2% |
| 427 | Endometrial Hyperplasia | 1.2% |
| 428 | Pyometra | 1.2% |
| 429 | Vaginitis | 1.2% |
| 430 | Vulvitis | 1.2% |
| 431 | Vaginal Discharge | 1.2% |
| 432 | Vulvodynia | 1.2% |
| 433 | Vesicovaginal Fistula | 1.2% |
| 434 | Hermaphroditism | 1.2% |
| 435 | Disorders of Sex Development | 1.2% |
| 436 | Hypospadias | 1.2% |
| 437 | Genital Herpes | 1.2% |
| 438 | Hypopharyngeal Neoplasms | 1.2% |
| 439 | Pleural Effusion, Malignant | 1.2% |
| 440 | Hypopharyngeal Cancer | 1.2% |
| 441 | Bladder neck obstruction | 1.1% |
| 442 | Parotid Neoplasms | 1.1% |
| 443 | Prostatic Neoplasms, Castration-Resistant | 1.1% |
| 444 | Nelson Syndrome | 1.1% |
| 445 | Oophoritis | 1.1% |
| 446 | Brain Stem Neoplasms | 1.1% |
| 447 | Cecal Neoplasms | 1% |
| 448 | Duodenal Neoplasms | 1% |
| 449 | Ovarian Diseases | 1% |
| 450 | Adnexitis | 1% |
| 451 | Cystitis | 1% |
| 452 | Hydronephrosis | 1% |
| 453 | Hyperoxaluria | 1% |
| 454 | Kidney Cortex Necrosis | 1% |
| 455 | Kidney Papillary Necrosis | 1% |
| 456 | Nephritis | 1% |
| 457 | Nephrosclerosis | 1% |
| 458 | Nephrosis | 1% |
| 459 | Perinephritis | 1% |
| 460 | Pruritus Vulvae | 1% |
| 461 | Kidney Failure | 1% |
| 462 | Uremia | 1% |
| 463 | Ureteral obstruction | 1% |
| 464 | Ureterocele | 1% |
| 465 | Urethral Obstruction | 1% |
| 466 | Urethritis | 1% |
| 467 | Uterine hemorrhage | 1% |
| 468 | Vaginal Fistula | 1% |
| 469 | Vesico-Ureteral Reflux | 1% |
| 470 | Urinary Retention | 1% |
| 471 | Pelvic Inflammatory Disease | 1% |
| 472 | Oxalosis | 1% |
| 473 | Renal Insufficiency | 1% |
| 474 | Uterine Prolapse | 1% |
| 475 | Vaginal Prolapse | 1% |
| 476 | Kidney Calculi | 1% |
| 477 | Ureteral Calculi | 1% |
| 478 | Choroid Plexus Papilloma | 0.9% |
| 479 | Tonsillar Neoplasms | 0.9% |
| 480 | Cerebellar Neoplasms | 0.9% |
| 481 | Nasopharyngeal Neoplasms | 0.9% |
| 482 | Colorectal Neoplasms | 0.9% |
| 483 | Diabetes Insipidus | 0.8% |
| 484 | Hepatorenal Syndrome | 0.8% |
| 485 | Dyspareunia | 0.8% |
| 486 | Paranasal Sinus Neoplasms | 0.8% |
| 487 | Bacteriuria | 0.8% |
| 488 | Diabetic Nephropathy | 0.8% |
| 489 | Glycosuria | 0.8% |
| 490 | Hematuria | 0.8% |
| 491 | Renal hypertension | 0.8% |
| 492 | Oliguria | 0.8% |
| 493 | Polyuria | 0.8% |
| 494 | Proteinuria | 0.8% |
| 495 | Pyuria | 0.8% |
| 496 | Renal Artery Obstruction | 0.8% |
| 497 | Renal Artery Stenosis | 0.8% |
| 498 | Urinary Calculi | 0.8% |
| 499 | Cystocele | 0.8% |
| 500 | Nephrocalcinosis | 0.8% |
| 501 | Urinary Incontinence | 0.8% |
| 502 | Radicular Cyst | 0.8% |
| 503 | Candidiasis, Vulvovaginal | 0.8% |
| 504 | Uterine Cervicitis | 0.8% |
| 505 | Leukorrhea | 0.8% |
| 506 | Parametritis | 0.8% |
| 507 | Pyelocystitis | 0.8% |
| 508 | Appendiceal Neoplasms | 0.8% |
| 509 | Colonic Neoplasms | 0.8% |
| 510 | Rectal Neoplasms | 0.8% |
| 511 | Enuresis | 0.7% |
| 512 | Gonadal Dysgenesis | 0.7% |
| 513 | Adrenogenital Syndrome | 0.7% |
| 514 | Ovotesticular Disorders of Sex Development | 0.7% |
| 515 | Pyelonephritis | 0.7% |
| 516 | Bacterial Vaginosis | 0.7% |
| 517 | Trichomonas Vaginitis | 0.6% |
| 518 | Uterine Perforation | 0.6% |
| 519 | Ovarian Hyperstimulation Syndrome | 0.6% |
| 520 | Maxillary Sinus Neoplasms | 0.6% |
| 521 | Glycosuria, Renal | 0.6% |
| 522 | Glomerulonephritis | 0.6% |
| 523 | Metrorrhagia | 0.6% |
| 524 | Nephritis, Interstitial | 0.6% |
| 525 | Lipoid nephrosis | 0.6% |
| 526 | Nephrotic Syndrome | 0.6% |
| 527 | Pyelitis | 0.6% |
| 528 | Pyonephrosis | 0.6% |
| 529 | Urethral Stenosis | 0.6% |
| 530 | Nephrogenic Diabetes Insipidus | 0.6% |
| 531 | Congenital Nephrogenic Diabetes Insipidus | 0.6% |
| 532 | Acute kidney injury | 0.6% |
| 533 | Urethral stricture | 0.6% |
| 534 | Anus Neoplasms | 0.6% |
| 535 | Sigmoid Neoplasms | 0.6% |
| 536 | AIDS-Associated Nephropathy | 0.6% |
| 537 | Hyperandrogenism | 0.6% |
| 538 | Azotemia | 0.5% |
| 539 | Anovulation | 0.5% |
| 540 | Menorrhagia | 0.5% |
| 541 | Albuminuria | 0.5% |
| 542 | Hemoglobinuria | 0.5% |
| 543 | Hypertension, Renovascular | 0.5% |
| 544 | Premature Menopause | 0.5% |
| 545 | Urge Incontinence | 0.5% |
| 546 | Renal Osteodystrophy | 0.5% |
| 547 | Renal rickets | 0.5% |
| 548 | Balkan Nephropathy | 0.5% |
| 549 | Focal glomerulosclerosis | 0.5% |
| 550 | Kidney Failure, Chronic | 0.5% |
| 551 | Polycystic Kidney Diseases | 0.5% |
| 552 | Diurnal Enuresis | 0.5% |
| 553 | Renal Aminoacidurias | 0.5% |
| 554 | Fanconi Syndrome | 0.5% |
| 555 | Pseudohypoaldosteronism | 0.5% |
| 556 | Liddle Syndrome | 0.5% |
| 557 | Hemolytic-Uremic Syndrome | 0.5% |
| 558 | Glomerulonephritis, Membranoproliferative | 0.4% |
| 559 | Chlamydia Infections | 0.4% |
| 560 | Gonorrhea | 0.4% |
| 561 | Turner Syndrome | 0.4% |
| 562 | Renal tubular acidosis | 0.4% |
| 563 | Zellweger Syndrome | 0.4% |
| 564 | Kallmann Syndrome | 0.4% |
| 565 | Syphilis | 0.4% |
| 566 | Anti-Glomerular Basement Membrane Disease | 0.3% |
| 567 | Lupus Nephritis | 0.3% |
| 568 | Polycystic Kidney, Autosomal Dominant | 0.3% |
| 569 | Cystinuria | 0.3% |
| 570 | Atypical Hemolytic Uremic Syndrome | 0.3% |
| 571 | Hyperphosphaturia | 0.3% |
| 572 | Klinefelter Syndrome | 0.3% |
| 573 | Lymphogranuloma Venereum | 0.3% |
| 574 | Familial Hypophosphatemic Rickets | 0.2% |
